Cyclo Therapeutics Correlations

CYTHW Stock

USD 0.23 0.01 4.17%

The current 90-days correlation between Cyclo Therapeutics and Falcon Metals Limited is -0.01 (i.e., Good diversification). The correlation of Cyclo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cyclo Therapeutics Correlation With Market

Significant diversification

The correlation between Cyclo Therapeutics and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more information on how to buy Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide.

Moving together with Cyclo Stock

0.78	CUE	Cue Biopharma	Pair Corr
0.66	OPT	Opthea Upward Rally	Pair Corr
0.66	GANX	Gain Therapeutics	Pair Corr
0.7	LTRN	Lantern Pharma	Pair Corr
0.8	DBVT	DBV Technologies Earnings Call Tomorrow	Pair Corr
0.87	OBI	Ondine Biomedical	Pair Corr
0.7	SSNLF	Samsung Electronics	Pair Corr

Moving against Cyclo Stock

0.85	INZY	Inozyme Pharma Earnings Call This Week	Pair Corr
0.76	KURA	Kura Oncology	Pair Corr
0.69	ABOS	Acumen Pharmaceuticals	Pair Corr
0.34	ILMN	Illumina Downward Rally	Pair Corr
0.85	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.8	TERN	Terns Pharmaceuticals	Pair Corr
0.76	ADTX	Aditxt Inc	Pair Corr
0.76	CTMX	CytomX Therapeutics Earnings Call This Week	Pair Corr
0.65	TCRX	Tscan Therapeutics	Pair Corr
0.52	STRO	Sutro Biopharma	Pair Corr
0.48	DAWN	Day One Biopharmaceu	Pair Corr
0.46	CNTA	Centessa Pharmaceuticals	Pair Corr
0.34	CRSP	Crispr Therapeutics	Pair Corr
0.57	TLKMF	Telkom Indonesia Tbk	Pair Corr
0.46	PTAIY	Astra International Tbk	Pair Corr
0.36	PIFMY	Indofood Sukses Makmur	Pair Corr
0.32	TLK	Telkom Indonesia Tbk	Pair Corr

Related Correlations Analysis

	CTYMF	UAL	EFRMF	LUV	FALFF	IONR
CTYMF		0.3	0.0	-0.88	-0.36	-0.07	CTYMF
UAL	0.3		0.0	-0.19	-0.17	0.17	UAL
EFRMF	0.0	0.0		0.0	0.0	0.0	EFRMF
LUV	-0.88	-0.19	0.0		0.36	0.09	LUV
FALFF	-0.36	-0.17	0.0	0.36		-0.25	FALFF
IONR	-0.07	0.17	0.0	0.09	-0.25		IONR
	CTYMF	UAL	EFRMF	LUV	FALFF	IONR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FALFF	+ 0.36	LUV
UAL	+ 0.3	CTYMF
IONR	+ 0.17	UAL
IONR	+ 0.09	LUV
EFRMF	+ 0.0	CTYMF
EFRMF	+ 0.0	UAL

High negative correlations

LUV	- 0.88	CTYMF
FALFF	- 0.36	CTYMF
IONR	- 0.25	FALFF
LUV	- 0.19	UAL
FALFF	- 0.17	UAL
IONR	- 0.07	CTYMF

Risk-Adjusted Indicators

There is a big difference between Cyclo Stock performing well and Cyclo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cyclo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CTYMF	3.12	0.42	0.08	0.68	3.49	(4.88)	8.81	(6.95)	27.62
UAL	2.04	(0.01)	0.00	(0.07)	0.00	0.00	3.34	(4.25)	10.91
EFRMF	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LUV	1.16	(0.03)	0.00	(0.16)	0.00	0.00	1.99	(2.61)	7.88
FALFF	90.28	47.39	0.00	1.75	0.00	0.00	0.00	0.00	3,051
IONR	3.32	(0.34)	0.00	(0.20)	0.00	0.00	6.70	(6.22)	32.97

Cyclo Therapeutics Corporate Management

Michael Lisjak	Global Development	Profile
George Fails	Ex Mang	Profile
Jeffrey Tate	Chief COO	Profile
Scott Fine	CEO Director	Profile
Lori McKenna	Global Advocacy	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC